Stay updated on Galcanezumab for Vestibular Migraine Clinical Trial
Sign up to get notified when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.

Latest updates to the Galcanezumab for Vestibular Migraine Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference6%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.SummaryDifference1.0%
- Check93 days agoChange DetectedThe website has posted completed results for version v2.13.3 on December 10, 2024, while the previous version v2.13.2 results submitted on February 3, 2023, have been removed.SummaryDifference2%
Stay in the know with updates to Galcanezumab for Vestibular Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galcanezumab for Vestibular Migraine Clinical Trial page.